Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry
Accessnewswire·2026-01-07 17:20

NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Emerging Growth Research today announced the release of its Flash Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), maintaining a Buy-Extended rating and its 12-month price target of 9.00,representingsignificantupsidefromtheCompany′sclosingpriceof9.00, representing significant upside from the Company's closing price of 4.44 on January 6, 2026. The Flash Report highlights SBC's major milestone entry into the United States medical aesthetics market through a strategic minority equity investment and structured col ...